PSA-Stratified Performance of [<sup>18</sup>F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy

PSA-Stratified Performance of [<sup>18</sup>F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy

Based on in vitro studies, it is known that androgen deprivation therapy (ADT) increases prostate-specific membrane antigen (PSMA) expression on prostate cancer (PCa) cells. However, ADT also has cytoreductive effects which can decrease lesion size. The present evaluation was conducted to further an...

Full description

Bibliographic Details
Main Authors: Sara Harsini, Don Wilson, François Bénard
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Diagnostics
Subjects:
prostate cancer
biochemical recurrence
prostate-specific membrane antigen
androgen deprivation therapy
Online Access:https://www.mdpi.com/2075-4418/12/9/2212

Similar Items

Similar Items